|
|
|
|
|||||
|
|
|
New: Introducing “Why Is It Moving?” - lightning-fast, AI-driven explanations of stock moves
Johnson & Johnson (NYSE:JNJ) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now.
Johnson & Johnson (NYSE:JNJ) is an American multinational pharmaceutical, biotech, and medical technologies company.
On October 14, the company announced that it will spin off its orthopedics division into a separate company within the next 18 to 24 months. This move marks its second major spin-off in two years as the healthcare giant continues to shift focus toward higher-growth segments.
Johnson & Johnson (NYSE:JNJ) also shared an optimistic outlook for 2026, supported by new drug launches and an expanding medical devices portfolio. J&J expects revenue growth to surpass 5% next year, above analysts’ forecasts of 4.6%, and projects adjusted earnings to exceed Wall Street’s estimate of $11.39 per share by up to 5 cents.
The orthopedics business, which produces implants for hips, knees, and shoulders as well as surgical instruments and related devices, generated about $9.2 billion in revenue last year, roughly 10% of the company’s total sales. After the separation, the new company will be called DePuy Synthes and led by industry veteran Namal Nawana.
In 2023, Johnson & Johnson (NYSE:JNJ) launched a two-year restructuring plan for its orthopedics unit, including market exits and product discontinuations, shortly after spinning off its $15 billion consumer health business into Kenvue.
Despite these major transformations, Johnson & Johnson (NYSE:JNJ) has continued to uphold its strong dividend tradition, having raised its payouts for 63 consecutive years. The company offers a quarterly dividend of $1.30 per share and has a dividend yield of 2.74%, as of October 14.
While we acknowledge the potential of JNJ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 11 Low PE High Dividend Stocks to Buy According to Analysts and 12 Reliable Dividend Stocks for Maximum Income.
Disclosure: None.
| 3 hours | |
| 3 hours | |
| 4 hours | |
| Oct-15 | |
| Oct-15 | |
| Oct-15 | |
| Oct-15 | |
| Oct-15 | |
| Oct-15 | |
| Oct-15 | |
| Oct-15 | |
| Oct-15 | |
| Oct-14 | |
| Oct-14 | |
| Oct-14 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite